Elmore Patent Law Group, P.C.
Hepatitis B antiviral agents
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. 
Enanta Pharmaceuticals, Inc.
C A C C C A A A C C C A C A
C07D A61K C07D C07D C07D A61K A61K A61K C07D C07D C07F A61K C07D A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Meizhong Wei Yao-Ling Yat Sun Xuri Xiaowen Hui Jorden
Jin Li Qiu Or Gao Peng Cao Kass